Debate: Echo Targeted Therapy for a PDA is the Standard of Care

Debate: Echo Targeted Therapy for a PDA is the Standard of Care is organized by NICUniversity.

Date Released: Jan 25, 2019
Valid Until: Jan 25, 2021

Credit Hours: 1.0 AMA PRA Category 1 Credit(s)™ 

Program Overview:
This presentation was originally given on December 5, 2018, at the Hot Topics in Neonatology conference in Washington, DC. This annual conference is sponsored by Nemours and seeks to involve clinicians from around the globe in the debate around both existing and emerging therapies and neonatal science, with the goal of providing clinicians with implementable practice change.

Learning Objectives:
By participating in this unit, participants should be able to:
• Evaluate the merits of clinical versus echocardiography assessment of the hemodynmic significance of PDA
• Discuss how targeted echo may enhance the clinical decision making process and quantification of PDA shunt volume
• Describe the known risks and benefits of persistent patency of the ductus arteriosus
• Describe the known risks and benefits of management strategies of the patent ductus arteriosus

Additional details will be posted as soon as information is available.